Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.

Maund SL, Barclay WW, Hover LD, Axanova LS, Sui G, Hipp JD, Fleet JC, Thorburn A, Cramer SD.

Cancer Res. 2011 Aug 1;71(15):5276-86. doi: 10.1158/0008-5472.CAN-10-2160. Epub 2011 Jun 8.

2.

Characterization of adult prostatic progenitor/stem cells exhibiting self-renewal and multilineage differentiation.

Barclay WW, Axanova LS, Chen W, Romero L, Maund SL, Soker S, Lees CJ, Cramer SD.

Stem Cells. 2008 Mar;26(3):600-10. Epub 2007 Nov 29.

3.

Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells.

Thorburn J, Moore F, Rao A, Barclay WW, Thomas LR, Grant KW, Cramer SD, Thorburn A.

Mol Biol Cell. 2005 Mar;16(3):1189-99. Epub 2005 Jan 5.

4.

Culture of mouse prostatic epithelial cells from genetically engineered mice.

Barclay WW, Cramer SD.

Prostate. 2005 May 15;63(3):291-8.

PMID:
15599944
5.
6.

Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells.

Rao A, Coan A, Welsh JE, Barclay WW, Koumenis C, Cramer SD.

Cancer Res. 2004 Mar 15;64(6):2143-7.

Supplemental Content

Loading ...
Support Center